A prospective study of Clostridium difficile infection and colonization in pediatric oncology patients

被引:31
作者
Burgner, D
Siarakas, S
Eagles, G
McCarthy, A
Bradbury, R
Stevens, M
机构
[1] ROYAL ALEXANDRA HOSP CHILDREN,DEPT MICROBIOL,PARRAMATTA,NSW,AUSTRALIA
[2] ROYAL ALEXANDRA HOSP CHILDREN,DEPT ONCOL,PARRAMATTA,NSW,AUSTRALIA
[3] CONCORD REPATRIAT GEN HOSP,DEPT MICROBIOL & INFECT DIS,CONCORD,NSW,AUSTRALIA
关键词
Clostridium difficile; oncology; nosocomial infection;
D O I
10.1097/00006454-199712000-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Patients with cancer often receive broad spectrum antibiotics in addition to antineoplastic chemotherapy. Both treatments predispose adult oncology patients to infection and colonization with Clostridium difficile, but the role of this pathogen in pediatric oncology patients is poorly defined. Methods. A prospective study of 149 fecal samples from symptomatic pediatric oncology patients and 58 samples from asymptomatic patients was performed. Each sample was analyzed for the presence of C. difficile and its toxins A and B. Results. In 8.7% of the symptomatic samples and 19% of the asymptomatic samples toxigenic C. difficile was found. No association was found between either the use of antibiotics and/or the administration of chemotherapy and the presence of toxigenic C. difficile. Younger children were more likely to be infected or colonized with C. difficile, and there was no evidence of nosocomial transmission of C. difficile within the study population. Conclusions. As toxigenic C. difficile may form part of the normal flora in young children, this study indicates that in the absence of a defined outbreak, C. difficile does not appear to be an important pathogen in pediatric oncology patients.
引用
收藏
页码:1131 / 1134
页数:4
相关论文
共 23 条
  • [1] CLOSTRIDIUM-DIFFICILE INFECTION ASSOCIATED WITH ANTINEOPLASTIC CHEMOTHERAPY - A REVIEW
    ANAND, A
    GLATT, AE
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 17 (01) : 109 - 113
  • [2] CLOSTRIDIUM DIFFICILE IN AN ONCOLOGY UNIT
    BRUNETTO, AL
    PEARSON, ADJ
    CRAFT, AW
    PEDLER, SJ
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1988, 63 (08) : 979 - 981
  • [3] ROLE OF CLOSTRIDIUM-DIFFICILE IN CHILDHOOD DIARRHEA
    CERQUETTI, M
    BIOL, D
    LUZZI, I
    CAPRIOLI, A
    SEBASTIANELLI, A
    MASTRANTONIO, P
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (07) : 598 - 603
  • [4] DONTA ST, 1982, J PEDIATR-US, V100, P431, DOI 10.1016/S0022-3476(82)80454-X
  • [5] DIMINISHED CLOSTRIDIUM-DIFFICILE TOXIN-A SENSITIVITY IN NEWBORN RABBIT ILEUM IS ASSOCIATED WITH DECREASED TOXIN-A RECEPTOR
    EGLOW, R
    POTHOULAKIS, C
    ITZKOWITZ, S
    ISRAEL, EJ
    OKEANE, CJ
    GONG, DH
    GAO, N
    XU, YL
    WALKER, WA
    LAMONT, JT
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) : 822 - 829
  • [6] Evaluation of two commercial microtiter cytotoxin assays for the detection of Clostridium difficile toxin B in stool specimens
    Fedorko, DP
    Williams, EC
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 26 (01) : 47 - 51
  • [7] EXTENDED SPECTRUM CEPHALOSPORINS AND CLOSTRIDIUM-DIFFICILE
    GOLLEDGE, CL
    MCKENZIE, T
    RILEY, TV
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (06) : 929 - 931
  • [8] HERD SR, 1986, J INFECT DIS, V153, P159
  • [9] CRYPTOSPORIDIUM SPECIES, A PROTEAN PROTOZOAN
    JANOFF, EN
    RELLER, LB
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (06) : 967 - 975
  • [10] CLOSTRIDIUM-DIFFICILE COLITIS
    KELLY, CP
    POTHOULAKIS, C
    LAMONT, JT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (04) : 257 - 262